mercredi 20 mai 2020

Onco Actu du 20 mai 2020


1. BIOLOGIE



Potentially cancerous cells kept in check by competitive neighbours, study of oesophagus finds [Sanger Institute]











Study suggests metastasis gets its start much earlier than thought [Medical XPress]











Why pancreatic ductal adenocarcinoma is so lethal [Cold Spring Harbor Laboratory]











New Study Confirms Important Clues to Fight Ovarian Cancer [Pacific Northwest Laboratory]











4.7 DÉP., DIAG. & PRONO. - COL DE L'UTÉRUS



Cervical precancer identified by fluorescence, in a step toward bedside detection [EurekAlert!]











5.12.5 IMMUNOTHÉRAPIES - PHARMA



Years after Keytruda, Roche's Tecentriq monotherapy wins first-line NSCLC approval. So does it matter? [EndPoints]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



AstraZeneca and Merck's Lynparza pressures Clovis' Rubraca with prostate cancer OK [Fierce Pharma]










Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer [AstraZeneca]











6.15 LUTTE CONTRE LES CANCERS - COVID-19



J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic [Fierce Pharma]











Special Report Provides Guidance to Oncology Practices on Resuming Cancer Care During COVID-19 Pandemic [ASCO]










Thousands of cancer patients could die early due to coronavirus delays, study finds [The Guardian]











Thousands of lives could be lost to delays in cancer surgery during COVID-19 pandemic [Institute of Cancer Research]










6.9 CONTROVERSES



Johnson & Johnson to End Talc-Based Baby Powder Sales in North America [NY Times]